When apatinib, PD-1 inhibitor, and CPT were administered, Nrf2 protein in mouse H22 tumor tissues was reduced and tumor growth was also inhibited after inhibiting Nrf2 protein expression. This evidence concerns the gene NFE2L2 and neoplasm.